Yangmeihui Song

746 total citations
27 papers, 498 citations indexed

About

Yangmeihui Song is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yangmeihui Song has authored 27 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Yangmeihui Song's work include Peptidase Inhibition and Analysis (8 papers), Cardiac Structural Anomalies and Repair (7 papers) and Protease and Inhibitor Mechanisms (6 papers). Yangmeihui Song is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Cardiac Structural Anomalies and Repair (7 papers) and Protease and Inhibitor Mechanisms (6 papers). Yangmeihui Song collaborates with scholars based in China, United States and Switzerland. Yangmeihui Song's co-authors include Xiaoli Lan, Dawei Jiang, Wenyu Song, Chunxia Qin, Liqiang Zhou, Fuqiang Shao, Xiangyi Ma, Weibo Cai, Qiqing Chen and Qingyao Liu and has published in prestigious journals such as Chemical Society Reviews, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Yangmeihui Song

24 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangmeihui Song China 14 196 153 145 88 83 27 498
Shanshan Qin China 10 166 0.8× 130 0.8× 149 1.0× 35 0.4× 42 0.5× 32 480
Xin Fan China 10 134 0.7× 138 0.9× 120 0.8× 33 0.4× 50 0.6× 28 463
Zhiying Shao China 12 174 0.9× 117 0.8× 95 0.7× 30 0.3× 69 0.8× 38 493
Da Li China 12 253 1.3× 163 1.1× 282 1.9× 64 0.7× 118 1.4× 33 728
Xianying Meng China 15 261 1.3× 113 0.7× 111 0.8× 38 0.4× 149 1.8× 38 529
Kai Ma China 15 261 1.3× 113 0.7× 49 0.3× 90 1.0× 39 0.5× 50 603
Minghua Ge China 15 270 1.4× 85 0.6× 186 1.3× 84 1.0× 112 1.3× 51 734
Maike Baues Germany 10 143 0.7× 218 1.4× 55 0.4× 50 0.6× 41 0.5× 11 576

Countries citing papers authored by Yangmeihui Song

Since Specialization
Citations

This map shows the geographic impact of Yangmeihui Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangmeihui Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangmeihui Song more than expected).

Fields of papers citing papers by Yangmeihui Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangmeihui Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangmeihui Song. The network helps show where Yangmeihui Song may publish in the future.

Co-authorship network of co-authors of Yangmeihui Song

This figure shows the co-authorship network connecting the top 25 collaborators of Yangmeihui Song. A scholar is included among the top collaborators of Yangmeihui Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangmeihui Song. Yangmeihui Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Yangmeihui, Jimin Hong, Axel Rominger, et al.. (2025). FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview. Seminars in Nuclear Medicine. 55(5). 710–723. 2 indexed citations
2.
Song, Yangmeihui, Jimin Hong, Carlos Ferreira, et al.. (2025). A mathematical model for the investigation of combined treatment of radiopharmaceutical therapy and PARP inhibitors. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3252–3265. 2 indexed citations
3.
Song, Yangmeihui, et al.. (2025). Mathematical and Computational Nuclear Oncology. PET Clinics. 21(1). 117–131.
5.
Song, Yangmeihui, Chunxia Qin, Yixiong Chen, et al.. (2024). Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation. European Journal of Nuclear Medicine and Molecular Imaging. 51(12). 3572–3584. 7 indexed citations
6.
Du, Fangxue, Yangmeihui Song, Kai Liu, et al.. (2024). Apoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell Death. Advanced Functional Materials. 34(44). 18 indexed citations
7.
Song, Yangmeihui, Jianhua Zou, Naomi Matsuura, et al.. (2024). Theranostics - a sure cure for cancer after 100 years?. Theranostics. 14(6). 2464–2488. 26 indexed citations
8.
Wang, Hao, Wen Li, Wei Hao, et al.. (2024). Liver-specific delivery of spherical DNA frameworks for alleviation of hepatic ischemic reperfusion injury. Journal of Nanobiotechnology. 22(1). 394–394. 4 indexed citations
9.
Hsu, Jessica C., Peng Liu, Yangmeihui Song, et al.. (2024). Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond. Chemical Society Reviews. 53(15). 7657–7680. 19 indexed citations
10.
Ji, Hao, Fuqiang Shao, Long Yu, et al.. (2024). [68Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [18F]FDG PET and CT. Pharmaceuticals. 17(6). 726–726. 9 indexed citations
12.
Shao, Fuqiang, Yu Long, Ziyang Zhu, et al.. (2022). Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer. Journal of Nanobiotechnology. 20(1). 243–243. 46 indexed citations
13.
Qin, Chunxia, Yangmeihui Song, Yongkang Gai, et al.. (2022). Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4228–4240. 21 indexed citations
14.
Wang, Yutong, Ke Zhu, Yangmeihui Song, et al.. (2022). Noninvasive Monitoring of Reparative Fibrosis after Myocardial Infarction in Rats Using 68Ga-FAPI-04 PET/CT. Molecular Pharmaceutics. 19(11). 4171–4178. 21 indexed citations
15.
Song, Wenyu, Yangmeihui Song, Qian Li, et al.. (2022). Advances in aptamer-based nuclear imaging. European Journal of Nuclear Medicine and Molecular Imaging. 49(8). 2544–2559. 42 indexed citations
16.
Song, Yangmeihui, Chunxia Qin, Fang Liu, & Xiaoli Lan. (2021). Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging. Clinical Nuclear Medicine. 46(9). 774–775. 11 indexed citations
17.
Qin, Chunxia, et al.. (2021). 68Ga-DOTA-FAPI-04 PET mimicking whole body bone scan in a patient with metabolic bone disease. European Journal of Nuclear Medicine and Molecular Imaging. 48(13). 4517–4518.
18.
Liu, Fang, Weiwei Ruan, Yangmeihui Song, et al.. (2020). Efficacy of delayed 18F-FDG hybrid PET/MRI for epileptic focus identification: a prospective cohort study. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 293–301. 8 indexed citations
19.
Qin, Chunxia, Fuqiang Shao, Fan Hu, et al.. (2019). 18F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 47(5). 1083–1093. 22 indexed citations
20.
Chung, Hee‐Jung, et al.. (2011). Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecologic Oncology. 120. S113–S113. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026